Medtronic (NYSE:MDT) is touting positive results from a study of its InterStim sacral nerve stimulator for treating less-severe overactive bladder syndrome, saying the device produces "superior efficacy and quality of life" compared with medication alone.
Neuromodulation/Neurostimulation
St. Jude touts clinical findings for migraine-treating neurostim implant
Medical device giant St. Jude Medical (NYSE:STJ) announced new clinical results for its migraine-management implants, reporting significant relief for patients who, on average, spend more days with migraines than without.
St. Jude lands Euro win for tiny migraine therapy implant
St. Jude Medical (NYSE:STJ) won European regulatory approval for its Eon Mini neurostimulator, which the company calls the smallest rechargeable device for treatment of chronic migraine.
Appeals court reverses $60M NuVasive trademark loss
NuVasive Inc. (NSDQ:NUVA) won a big legal victory yesterday when a federal appeals court reversed a lower court’s $60 million decision in favor of NeuroVision Medical Products, rebuking the lower court judge in the process.
The decision means the case pitting the medical device companies against each other will be re-tried under a different district court judge.
Judge nixes $42M Orthofix, Justice Dept. settlement
CircuLite, NeuroSigma land CE Marks
The European Union granted CE Mark approval to a pair of medical device companies, CircuLite and NeuroSigma, for their technologies designed to treat heart failure, epilepsy and depression.
FDA hands rehab devices startup Hollywog 2 wins for wireless back pain systems
Rehab and physical therapy devices startup Hollywog landed a pair of FDA nods for its wireless back pain therapy devices, the WiTouch and the WiTouch Pro.
The devices use transcutaneous electrical nerve stimulation, a process in which electrical signals are transmitted through the skin to stimulate nerve or muscle fibers, to suppress pain signals before they they reach the brain and ramp up the body’s production of pain-relieving endorphins, according to the company’s website.
Boston Scientific wins expanded CE Mark for Precision Plus spinal cord stimulator
Boston Scientific (NYSE:BSX) touted CE Mark approval in the European Union for its Precision Plus spinal cord stimulator, which U.K. regulators also cleared for use during head-only MRI scanning.
The weight loss pacemaker: MassDevice Q&A with EnteroMedics
EnteroMedics (NSDQ:ETRM) is looking to control metabolic disease by attacking the problem closer to its source – human behavior.
FDA approves Codman implantable infusion pump for treatment of movement disorders
The FDA granted PMA supplemental approval to Codman & Shurtleff for the Medstream programmable infusion device, an implantable infusion pump and catheter used in treatment of movement disorders.
The Medstream system delivers continuous doses of an anti-spasm drug directly to he spinal canal to relieve spasticity, a disorder affecting more than 12 million people worldwide, which is often caused by stroke, cerebral palsy, multiple sclerosis or spinal cord injury, according to the company.
Medtronic-backed study implants 1st Alzheimer’s patient with brain “pacemaker”
Researchers in the U.S. and Canada launched a clinical trial evaluating the safety and efficacy of deep-brain stimulation in treatment of mild Alzheimer’s disease.
The study will enroll 20 people aged 55-80 with Medtronic’s (NYSE:MDT) deep brain stimulation technology, surgically implanted devices that are similar to a cardiac pacemaker and that deliver electrical pulses to targeted areas of the brain.